Mingjun T. Sun

155 Nanjing Bei Road, 
Shenyang, CN 
155 Nanjing Bei Road, 
Shenyang, CN 

Overview

Mingjun Sun practices practicing medicine in Shenyang, China.

Their clinical expertise encompasses Esophageal Cancer, Stomach Cancer, Colorectal Cancer, Gastrointestinal Bleeding, and Endoscopy.

They are actively involved in clinical research, co-authoring 68 peer reviewed articles and participating in 2 clinical trials.

Locations

155 Nanjing Bei Road, Shenyang, 110001, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-blind, Placebo Parallel Controlled Clinical Study on the Effecacy and Safety of Different Dosing Regimens of Hemay007 in Patients With Active Ulcerative Colitis
A Multicenter, Randomized, Double-blind, Placebo Parallel Controlled Clinical Study on the Effecacy and Safety of Different Dosing Regimens of Hemay007 in Patients With Active Ulcerative Colitis
Enrollment Status: Terminated
Publish Date: March 01, 2024
Intervention Type: Drug
Study Drug: Hemay007
Study Phase: Phase 2
A Phase 3 Study to Evaluate the Efficacy and Long-term Safety of SHR0302 Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Study to Evaluate the Efficacy and Long-term Safety of SHR0302 Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Enrollment Status: Unknown
Publish Date: September 05, 2023
Intervention Type: Drug
Study Drug: SHR0302
Study Phase: Phase 3
View 1 Less Clinical Trial

68 Total Publications

The Enterococcus-putrescine-hadh axis drives mitochondrial redox imbalance and endothelial barrier breakdown in aortic dissection.
The Enterococcus-putrescine-hadh axis drives mitochondrial redox imbalance and endothelial barrier breakdown in aortic dissection.
Journal: Redox biology
Published: July 07, 2026

Frequently Asked Questions about Mingjun T. Sun

Is Mingjun T. Sun a top-rated expert for Esophageal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Mingjun T. Sun is classified as an Experienced expert for Esophageal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mingjun T. Sun participate in research or clinical trials?

Yes. Mingjun T. Sun has published 68 articles and abstracts on conditions like Esophageal Cancer. You can view a list of Mingjun T. Sun's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sun's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile